Over the past year, new launches in the injectable GLP-1 agonist segment, including tirzepatide and semaglutide, drove a 177 per cent rise in sales in this category on a moving annual turnover (MAT) basis to Rs 1,446 crore in February 2026, compared with Rs 571 crore in February 2025
Patients who receive B12 shots alongside testosterone therapy often report more stamina during workouts and shorter recovery times
This dual action means it can: Control appetite even better than single-hormone medications Improve blood sugar control more effectively Lead to greater weight loss in many people Help your body use insulin more efficiently Tirzepatide is sold under the brand names Mounjaro for diabetes and Zepbound for weight loss
This demographic shift is encouraging healthcare providers to expand antioxidant and longevity-focused treatment offerings
Honey smooths out the sharpness of the apple cider vinegar in Lazy Dogs new dressing, just as Cuba Libres citrus-garlic sauce lightens the brisket in its GLP-1-friendly Vaca Frita
doi: 10.1007/s11126-020-09789-4 88 MansellVHall DykgraafSKiddMGoodyear-SmithF